This paper presents findings from the Alliance for Research in El Barrio and Bayamó n (ARIBBA) research study, which compared HIV-related risk behaviors, HIV infection rates, and mortality rates of 800 Puerto Rican injection drug users and crack smokers in East Harlem, New York, with 399 of their counterparts in Bayamó n, Puerto Rico. The study was conducted from 1996 to 2004 and is among the most comprehensive ever undertaken on HIV risk behaviors of drug users in Puerto Rico. This paper presents the main findings, many of which have been published in scientific journals. The study found that drug users in Puerto Rico became infected with HIV at a rate almost 4 times higher than Puerto Rican drug users in New York, and they died at a rate that was more than 3 times as high. The findings indicate that drug users in Puerto Rico are more likely than Puerto Rican drug users in New York to engage in injection drug use and sexual behaviors that put them at risk of becoming infected with HIV. In addition, they have fewer prevention resources available to them. HIV prevention programs are scarce in Puerto Rico and the availability of drug treatment programs in Puerto Rico declined by over one third during the period examined. Additionally, significantly fewer HIV-positive drug users in Puerto Rico were taking HIV-related medications than in New York. The paper concludes with recommendations and lessons learned from the study.
Introduction to Study and Summary of Main Findings
There is a public health emergency among drug users in Puerto Rico. Drug users in Puerto Rico are becoming infected with HIV at rates that are among the highest anywhere in the United States. In 2007, Puerto Rico had the sixth highest rate of new AIDS cases among all the states and territories of the United States, and the rate of children living with the disease was almost 60% higher than the national average. It also has one of the largest numbers of reported AIDS cases among Caribbean nations. Puerto Rico's AIDS epidemic has been driven largely by injection drug use. This paper presents findings from the Alliance for Research in El Barrio and Bayamón (ARIBBA) research study, which compared HIV-related risk behaviors, HIV infection rates, and mortality rates of 800 Puerto Rican injection drug users and crack smokers in East Harlem, New York, with 399 of their counterparts in Bayamón, Puerto Rico. The study's main findings are discussed, many of which have been published in scientific journals, as well as findings from a federally funded study on trends in Puerto Rico's drug treatment services and an examination of death rates among project participants. As of December 2009, more than 30 articles based on findings from the ARIBBA study have been published in scientific journals and the findings have been presented at over 40 scientific conferences. These findings have also been summarized in a report available in both English and Spanish at: http:// www.cduhr.org/pub/reports.aspx.
The study was conducted from 1996 to 2004 and was funded by the National Institute on Drug Abuse. It is among the most comprehensive studies ever undertaken on HIV risk behaviors of drug users in Puerto Rico. The study used both quantitative and qualitative methodologies and the findings are based on initial and follow-up interviews and HIV tests. Where appropriate, we present updated statistics on HIV prevalence.
The study found that during the period examined, drug users in Puerto Rico became infected with HIV at a rate almost 4 times higher than Puerto Rican drug users in New York, and they died at a rate that was more than 3 times as high.
The findings indicate that drug users in Puerto Rico are more likely than Puerto Rican drug users in New York to engage in injection drug use and sexual behaviors that put them at risk of becoming infected with HIV. In addition, they have fewer prevention resources available to them. HIV prevention programs that have been proven to reduce the number of drug users who contract the virus, such as methadone maintenance and needle exchange programs (NEPs), are scarce in Puerto Rico, and the availability of drug treatment programs in Puerto Rico declined by over one third during the period examined. Additionally, the use of health care services among drug users in Puerto Rico is relatively low. For example, significantly fewer HIV-positive drug users in Puerto Rico were taking HIV-related medications than in New York.
While the AIDS epidemic in Puerto Rico has been driven mainly through infections among injection drug users, the disease has wide-reaching health and social effects. Drug-related transmission has historically been HIV's main route into heterosexual and non drug-using communities, suggesting that it is a factor in the rate of AIDS among Puerto Rico's general population, including children. Additionally, HIV affects the families of those who are infected and depletes resources from health care systems that are already overburdened.
The rate of new HIV infections can be reduced. HIV prevention programs for drug users reduce risk behaviors, thereby reducing transmission rates and the number of new infections. In fact, the study found that drug users in Puerto Rico who had migrated to New York, where there are substantially more HIV prevention programs, were less likely to practice high-risk HIVrelated drug injection than drug users who remained in Puerto Rico. We conclude the paper with lessons learned and recommendations on ways to address the public health threat posed by the rate of HIV/AIDS among drug users in Puerto Rico.
Overview of the ARIBBA Project and Study Design
The ARIBBA research project is a longitudinal study, funded by the National Institute on Drug Abuse, which compared the HIV-related risk behaviors of 800 Puerto Rican adult injection drug users (IDUs) and crack smokers recruited in East Harlem, New York, with 399 of their counterparts in Bayamón, Puerto Rico. The participants were recruited between January 1998 and August 1999 and follow-up interviews were conducted through 2003. The study was conducted by 2 teams of researchers; one at the National Development and Research Institutes, Inc. (NDRI) in New York, led by Dr Sherry Deren, Principal Investigator (PI), and one at the Universidad Central del Caribe in Puerto Rico, led by coinvestigators Drs Rafaela Robles and Hector M. Colón.
The more than 30 published articles based on findings from this study have compared study participants in the 2 locations, including their injection-related HIV risk behaviors, sexrelated risk behaviors, and their utilization of drug treatment, health care, and NEPs. The articles have also examined factors that affect risk behaviors, such as the influence of peers on drug injection practices and histories of physical and sexual abuse. Other publications have reported on the study design, including its integration of quantitative and qualitative methodologies, the ethnographic methods used to identify participant recruitment locations, and the results of a biculturality scale incorporated in the survey instrument.
Citations are provided throughout this paper for findings that have been published. Findings that have not yet been published, that were presented at conferences, published as part of another study, or that are from secondary sources, are identified as such. Since the publications examine different aspects of HIV risk among the study participants, different statistical analyses and sample sizes were used. We therefore encourage the reader to refer to the original sources for a complete discussion of the methodologies used in each analysis.
Research Design and Methods
The ARIBBA study design was uncommon in that it compared persons of the same ethnic background-Puerto Rican-in 2 locations. This design allowed us to compare study participants of the same background who lived in 2 different environments, East Harlem, New York, and Bayamón, Puerto Rico. We also examined the risk behaviors of participants who had used drugs in Puerto Rico and subsequently emigrated from Puerto Rico to New York, referred to as ''migrants,'' with Puerto Rican drug users recruited in New York who were not migrants. Doing so allowed us to examine whether HIV-related risk behaviors differ in an environment with few HIV prevention resources, compared with an environment where there are many.
The ARIBBA study is based on quantitative and qualitative methods. 1 The quantitative component included structured interviews and HIV testing with participants at several time points. The qualitative methods included mapping the geographic study areas, focus groups with drug users, field observations of service providers and drug selling and using areas, and in-depth ethnographic interviews.
Communities
Participants in New York were recruited in East Harlem, a neighborhood in Northern Manhattan that covers approximately 3 square miles. At the start of the study, East Harlem, also known as ''El Barrio'' and Spanish Harlem, had a population of 110 000 residents, 52% of who were Latino (primarily Puerto Rican), 41% African American, and 7% White. When recruitment began, the neighborhood had one of the highest total cumulative AIDS rates in New York City-4594 per 100 000 persons. 1 Study participants in Puerto Rico were recruited from the municipality of Bayamón, part of the San Juan metropolitan area and located southwest of San Juan. Bayamón is home to approximately 220 000 people and is a predominantly urban area comprised of 45 square miles. At the start of the study, San Juan had the 6th highest AIDS rate when counted among US metropolitan areas. 2 Participants in both locations were recruited between January 1998 and August 1999. The Bayamón and East Harlem recruitment areas were divided into 3 and 5 recruitment sectors, respectively, which were identified through ethnographic mapping techniques. Recruitment sectors were similar in size and daily recruitment locations were randomly selected from within the sites. Trained outreach workers, who were indigenous community members and who had previously conducted similar research and HIV-related work in the areas, identified potential study participants.
Procedures
To be eligible for the study, participants in both locations had to meet the following criteria: (1) 18 years of age or older, (2) self-identification as Puerto Rican, and (3) report injecting drugs or smoking crack within the past 30 days.
Prospective study members who met the criteria were asked to come to the field site, where staff provided information about the study and informed consent was obtained. Urinalysis testing (using Roche ONTRAK), was administered to confirm heroin or cocaine use within the previous 48 hours. Participants were interviewed using a computer-assisted baseline interview, which took an average of one and a half hours to complete, and they were paid a $15 research stipend in New York and $20 in Puerto Rico. After the interview, study members received HIV pretest counseling and were offered HIV testing (using ORA-SURE). Participants who were tested were given a follow-up appointment approximately 1 week later to return for test results and posttest counseling. Participants were interviewed at baseline and at approximately 6, 36, and 42 months after baseline. More than 80% of the participants received at least one follow-up interview.
The survey instrument gathered data to examine a variety of possible influences on HIV risk behavior. The instrument included items to assess the following characteristics: demographics, psychological status (eg, depression), social (eg, networks of other users), health-related (e.g., HIV status), cultural (e.g., biculturality), environmental (e.g., availability of NEPs), lifetime, and past 30-day history of drug use, drug treatment, and 30-day history of injection and sex-related risk behaviors. The instruments were translated from English to Spanish and then back-translated to ensure comparability in both languages. All study protocols and interview instruments were approved by the local Institutional Review Boards. 4 In a separate analysis conducted by the Puerto Rico Department of Health and the CDC, based on the 33 US states and 5 territories that conduct confidential, name-based HIV reporting, even higher rates were reported. 5 This study found that in 2006, the estimated HIV incidence rate in Puerto Rico was 45 cases per 100 000 population-a rate that was twice that of the 50 US states.
Overview of AIDS and HIV in Puerto Rico
Puerto Rico also has one of the highest rates of HIV/AIDS in the Caribbean and in Latin America. Cases of HIV and AIDS are often underestimated because many people do not know that they are infected and because many countries, particularly those with limited resources, do not have adequate surveillance and monitoring systems. However, based on known cases, Puerto Rico is among the Caribbean nations with the highest number of cumulative AIDS cases. 6 Puerto Rico is often omitted from comparative regional and nationwide studies of HIV infection and AIDS diagnoses. While the explanation for the exclusion is beyond the scope of this report, geopolitical factors may play a role. Comparisons of HIV and AIDS within the Caribbean are usually based on differences between independent nations and therefore do not include Puerto Rico since it is a commonwealth of the United States. Likewise, comparative studies within the United States are often limited to the 50 states and do not include US territories. As a result, although the HIV/AIDS epidemic in Puerto Rico is one of the largest domestically and in the Caribbean, it is often overlooked in nationwide and regional analysis.
HIV/AIDS among Latinos and Puerto Ricans
Latinos in the United States have been disproportionately impacted by HIV since the start of the epidemic and they are now the largest ethnic or racial group in the United States. While Latinos comprise 13% of the nation's population, 7 they account for 19% of all persons living with AIDS at the end of 2007. 4 The rate of infection among the Puerto Rican community, however, has been the highest of any Hispanic group. 8 The majority of HIV-positive Puerto Ricans, including those living in the United States and in Puerto Rico, contracted the virus though injection drug use or through sex with an HIVpositive drug user. This contrasts with HIV-positive Latinos of other nationalities, whose primary HIV transmission route has been through sexual contact between men. In 2007, the main exposure category for foreign-born Latinos who were diagnosed in the United States, including Cubans, South Americans, Mexicans, and other Central American groups, was through sexual contact between men (47%). According to the CDC, the largest risk category among Puerto Ricans in the United States, who were born in Puerto Rico, was injection drug use (45% were IDU or both IDU and MSM), whereas drug injection accounts for less than 20% among all of the other foreign-born Latino groups noted.
Differences in HIV transmission risk categories between Latino subgroups are often missed when examining US HIV and AIDS data among Latinos overall. Some Latino groups are much larger than others-Mexicans, for example, comprise almost 60% of the country's Hispanic population while Puerto Ricans make up about 10%. 7 When Latino subgroups are combined as one group on HIV reporting systems and surveillance reports, Puerto Ricans are subsumed into the broader category. Since most HIV-positive Puerto Ricans became infected through injection drug use while other Latinos were infected primarily through sex between men, and because Puerto Ricans comprise a relatively small percentage of the Hispanic community nationwide, conclusions based on ''Hispanic'' HIV/AIDS infection rates and risk categories miss or obfuscate important distinctions, and can therefore be misleading.
The CDC and local and state health departments distinguish between foreign-born Latinos, including those born in Puerto Rico, but generally combine US-born Hispanics into one group when collecting data on HIV/AIDS and on other health statistics. This process does not permit making comparisons between different U.S. born Latino groups or from comparing immigrant and nonimmigrant Hispanics of the same background. Because US-born Latinos now outpace immigrants as the main source of growth within the Hispanic population, 9 it is increasingly important to be able to study differences among subgroups.
Characteristics of Study Participants Baseline Demographic Characteristics
Approximately half of the participants recruited in New York City were born in Puerto Rico, and 45% were born in New York. By contrast, 86% of the participants in Puerto Rico were born there. 1, 10 The majority of participants were male; 73% of those in New York and 79% of the Puerto Rico sample ( Table 1 ). The drug users recruited in Puerto Rico were significantly younger than those in New York, an average of 33 years of age versus 38 years among their New York counterparts. At baseline, 20% of the participants in Puerto Rico were HIV-positive compared to 25% of those in New York.
Participants in Puerto Rico were more likely to have completed high school or to have a General Equivalency Diploma (GED) than participants in New York, 46% versus 38%, respectively. The majority of participants in both sites were poor. About 40% of all participants reported incomes of less than $500 in the 30 days prior to their baseline interviews. About a third of those in Puerto Rico reported incomes over $999 during this period, compared to a quarter of their New York peers. About half of the participants in both sites were single and the New York participants were more likely to be married or in common law relationships, 26% compared to 19% in Puerto Rico.
The majority of participants reported having been in jail or prison at some point in their lives. Eighty seven percent of the New York sample and approximately three quarters of the sample in Puerto Rico reported having been incarcerated. The 2 groups also differed in their residential status. Almost half (43%) of Puerto Rican participants were living in their parents' home, compared to 13% of those in New York. Similar proportions in both locations were homeless-19% and 22% in Puerto Rico and New York, respectively.
Baseline Drug Use Patterns
The ARIBBA study recruited drug users who injected drugs, smoked crack or did both, in the month before their first interviews. 1 As Table 2 shows, drug users recruited in Puerto Rico were more likely to have used drugs through injection only than users in New York, 53% versus 39%, respectively. In New York, 30% of users used crack only, compared to 22% of the Puerto Rico sample. Overall, about three quarters of all study participants had injected drugs within the 30 days prior to the baseline interview. Those in New York were more likely to have also used crack. There were differences between participants in the 2 study sites in the substances that they injected in the month before their first interview. 11 As Table 2 shows, 91% of drug injectors in Puerto Rico reported injecting a combination of heroin and cocaine, called speedball, compared to 54% of users in New York. Drug injectors in Puerto Rico were also more likely to have injected cocaine alone; two thirds, compared to less than half of New York participants. In contrast, injection drug users in New York were more likely to have injected heroin by itself-88% versus 66% of users in Puerto Rico. Finally, the injection of cocaine alone and the injection of speedballs, both of which were more common among drug injectors in Puerto Rico, were each found to increase the frequency of drug injection by about 30%.
HIV-Related Drug Injection and Sex Risk Behaviors Drug Injection Behaviors and HIV Risk
Drug injectors in Puerto Rico injected drugs more often and reused syringes more frequently than their New York counterparts. 1, 11, 12 In the 30 days before their baseline interviews, study members in Puerto Rico injected drugs more than twice as often-an average of 184 times a month, versus 76 times in New York (P < .001), and they reused each syringe more than twice as often, an average of 6 times per needle compared to 2.9 times (P < .001), respectively. Reusing syringes increases the likelihood that they will clog, which in turn increases the risk that drug injectors will use someone else's needle.
During a focus group with injection drug users in Puerto Rico, participants explained how a clogged syringe is related to risky drug injection. According to one focus group member, ''If my syringe clogs and I have to ask to borrow one, it doesn't matter to me if it's infected or whatever, what's important is to get a fix (curarme).'' Study participants in Puerto Rico were almost 3 times more likely to use someone else's needle and almost 4 times more likely to loan someone their needle (Graph 1). They were also more likely to share paraphernalia used to prepare and inject drugs, such as cookers and rinse water. In addition to HIV transmission risk, other research has shown that sharing drug injection paraphernalia increases the risk of Hepatitis C (HCV) transmission. 13 Drug-shooting galleries are environments that increase the risk of contracting HIV because they are associated with sharing injection equipment. Almost 80% of participants in Puerto Rico, compared with 23% of those in New York, used injection-shooting galleries in the month prior to their first interviews. Buying drugs collectively also increases the risk of contracting HIV because persons who pool their money for drugs are more likely to share needles and injection paraphernalia. Approximately three quarters (72%) of drug injectors in Puerto Rico pooled their money together with other drug users to purchase drugs, compared to 44% of those in New York. 14 The majority of study participants in both locations had been in jail or prison at some point in their lives-74% in Puerto Rico and 87% in New York. 15 Those who injected drugs while they were incarcerated practiced high-risk drug injection during their incarcerations. Almost a third of the participants in Puerto Rico who were injection drug users reported injecting drugs during their last incarceration, significantly more than the 12% who reported the behavior in New York. who injected in prison, about three quarters of those in Puerto Rico shared injection-related equipment with other users, compared to slightly over half in New York. In contrast to Puerto Rico, where injecting drugs during the last incarceration was more common, 37% of users in New York practiced noninjection drug use during their detentions, compared to 14% in Puerto Rico. Almost three quarters of drug users in Puerto Rico reported being in a prison association or gang (eg, Netas, Latin Kings) during their last incarceration, compared to about a third of users in New York (Table 3) .
Sex Behaviors and HIV Risk
Crack smokers in both locations were more likely than drug injectors to have had sex in the 30 days prior to their baseline interviews (Table 4 ). 1, 16 About three quarters of study participants in both study sites who used only crack reported engaging in sex, compared to about half of those who injected drugs. Among those who reported sexual behavior, women drug injectors and crack smokers were more likely than men to trade sex for drugs or money. Women in Puerto Rico who injected drugs or smoked crack were more than twice as likely as their counterparts in New York to have exchanged sex for drugs or money. Both male and female drug injectors and crack smokers in Puerto Rico were more likely to have had multiple sex partners than those recruited in New York. Participants in Puerto Rico who had sex were also more likely to have had unprotected sex than those in New York. 16 As shown in Table 5 , in the 30 days prior to their baseline interviews, 80% of participants in Puerto Rico who reported sex with their main partner had unprotected sex, compared to 64% of participants in New York. Among users who reported having sex with a casual partner, almost 70% of those in Puerto Rico had unprotected sex, a rate almost double that of participants in New York. Study participants were least likely to have unprotected sex with paid partners (about one third in both locations). During focus groups and individual qualitative interviews, participants in both study sites said that condoms were more likely to be used in New York than in Puerto Rico. The reasons attributed to their more frequent use included religion and culture, as well as their greater availability and free distribution. 17 
HIV Prevention and Health Services
In this section, we compare the utilization of drug treatment and HIV prevention programs among study participants in Puerto Rico and New York. We also include the findings from another federally funded study that surveyed Puerto Rico's drug treatment services in 1998 and 2002.
Drug Treatment Programs
There are substantially more drug treatment and risk reduction programs available to drug users in East Harlem, New York than in Bayamón, Puerto Rico. At the time that participants were recruited (1998 to 1999), there were 5 methadone maintenance treatment programs with 12 clinics operating in East Harlem. In contrast, Bayamón had just 1 methadone program with a single clinic site.
There were also significant differences in the types of drug treatment programs that participants used. 18 At the 6-month follow-up interview, participants were asked about the types of drug treatment programs they had used during the prior 6 months. Participants in New York were 14 times more likely than those in Puerto Rico to have used a methadone maintenance treatment program (MMTP)-63% versus 5%, respectively ( Table 6 ). Residential/inpatient drug treatment was the most common form of drug treatment used by participants in Puerto Rico. A total of 18% reported using inpatient/ residential treatment compared to 4% in New York. Among those who were incarcerated during the 6-month follow-up period, participants in New York were more likely than those in Puerto Rico to receive drug treatment, 34% versus 20%, respectively. Overall, participants in Puerto Rico were less likely to report use of drug treatment. Approximately 56% (55.7%) received drug treatment during the past year, compared to 79.4% in New York (not shown).
Needle Exchange Programs
East Harlem had 4 NEPs at the start of the study, while in Bayamón there was 1 mobile program. In addition, the East Harlem NEPs operated for more hours per week and had less restrictive exchange policies. Study findings also show that drug users in Puerto Rico received fewer services from NEPs than their counterparts in New York. 12 Drug injectors in both locations used NEPs at similar rates-an average of 3 times in Puerto Rico and 2.8 times in New York, during the 30 days before their baseline interview. There were, however, significant differences in the number of needles they obtained and in the percentage who received referrals to other programs. Drug injectors in New York received an average of 105 needles from syringe exchange programs during the 30 days prior to the interview, while in Puerto Rico they received an average of 9. These differences are particularly striking in view of the finding that drug injectors in Puerto Rico injected drugs more than twice as often as those in New York. In addition to distributing new syringes, NEPs can provide referrals to drug treatment programs and health care services. In comparison to New York, drug users in Puerto Rico received significantly fewer referrals from NEPs in the month before their first interview (Table 7) . Only 15% of injectors in Puerto Rico were referred to a drug treatment program, compared to almost 70% of their counterparts in New York (P < .001). Twelve percent of injectors in Puerto Rico were referred to an HIV testing facility and 8% to a tuberculosis testing site, compared to 66% and 58%, respectively, in New York (P < .001). Finally, nearly all participants in New York received condoms from NEPs, compared to 79% in Puerto Rico (P < .001).
Participants in Puerto Rico obtained syringes from sources different than those in New York. In the month before their baseline interview, over half of the needles used by New York injection drug users were obtained through syringe exchange programs, while only 18% of the needles used by participants in Puerto Rico came from this source ( Table 7) . Private sellers were the most common source of needles in Puerto Rico: 45% of the syringes used by drug injectors came from private sellers, compared to 23% in the New York sample.
The ethnographic component of the study found that syringe sellers in Puerto Rico are often older men and women who do not use illegal drugs. They typically buy syringes in bulk from pharmacies and then sell them individually for $1.00. However, according to participants interviewed in focus groups and information obtained through participant observation, the $1.00 cost prevents some drug injectors from buying as many new syringes as they need.
Drug users in Puerto Rico were more likely to obtain their syringes from pharmacies-18% compared to 4% of those used in New York. A possible explanation for the difference is that during the time that study participants were recruited, New York law required a prescription to buy needles while in Puerto Rico they could be purchased over the counter. In 2001, New York State enacted the Expanded Syringe Access Demonstration Program (ESAP), which allows the purchase of up to 10 syringes from pharmacies without a prescription. Although drug users in Puerto Rico were not legally prohibited from buying needles from pharmacies during the period examined, study findings suggest that the practice is discouraged. For example, some pharmacies require proof of a medical condition that necessitates using a syringe and others do not sell individual needles. Participants also reported that they were sometimes harassed by the police for carrying drug paraphernalia.
Use of Health Services and HIV Medications
At the 6-month follow-up interview, study members were asked about the types of health services that they had used over the previous 6 months (Table 8 ). Participants who were HIV positive were asked whether they were taking HIV medications. 18 Drug users in Puerto Rico were significantly less likely to report using HIV-related medical and mental health services or to have taken HIV medications. Only 3% used HIV-related inpatient medical health services and 5% used outpatient services, compared to 19% and 65%, respectively, in New York. Drug users in Puerto Rico were also 6 times less likely to use mental health services-3% compared to 18% in New York. Perhaps most alarming, among participants who were HIV positive, 22% in Puerto Rico reported taking HIV-related medications, compared to 52% in New York.
Declines in Puerto Rico's Drug Treatment Services and Capacity
The number of people who received drug treatment services in Puerto Rico declined during the study period. Surveys of all drug treatment providers in Puerto Rico, 19 conducted in 1998 and in 2002, found that the number of persons who received some type of drug treatment declined by almost 42% during this period. As shown in Graph 2, in 1998 over 14 000 persons were treated in a drug treatment program and in 2002 this number had declined to 8305. There was also a significant decline in the number of persons who received alcohol treatment in Puerto Rico between these 2 years: 3700 patients in 1998 and 2200 in 2002, a 39% reduction ( Table 9 ). The capacity of treatment programs, as measured during a 1-month period, declined by 35%, from approximately 21 000 to about 14 000. The use of these programs also declined, from running at 86% capacity in 1998 to 78% in 2002. The decline in use may be due to drug users learning of the reductions in treatment slots, which discouraged them from trying to enroll in treatment. Finally, the number of full-time drug treatment program employees also dropped sharply, from almost 3000 in 1998 to about 1900 4 years later-a 37% decline.
Risk Behaviors Decline after Emigrating to Environment with More HIV-Prevention Resources
We also examined the risk behaviors of injection drug users in Puerto Rico who had emigrated to New York City. 20 A substantial number of injectors that were recruited in New York (39%) were migrants. Migrants were defined as those who had injected drugs in Puerto Rico and who used drugs there for at least 1 year.
Overall, migrant drug users practiced riskier HIV-related drug injection than nonmigrant injectors recruited in New York. For example, 41% of migrants who injected drugs shared injection paraphernalia (during the 30 days prior to the baseline interview), compared to 28% of nonmigrants. However, migrants engaged in less-risky injection behaviors than study participants in Puerto Rico. Migrants in New York were more likely to report high HIV-risk injection than nonmigrants in terms of their frequency of monthly injections (87 versus 69, respectively; P < .05) and in the use of shooting galleries (32% versus 18%, respectively; P < .001). However, migrants were less likely to report high HIV-risk injection behaviors than the injection drug users recruited in Puerto Rico (32% versus 79%, P < .001).
The differences suggest that the greater availability of drug treatment and HIV prevention programs in New York helps reduce injection risks. Some migrants emigrated to New York to obtain drug treatment services. During focus groups with migrant drug injectors, several participants said that they had traveled to New York to enroll in methadone maintenance treatment programs and obtain other services.
HIV Incidence, Drug Overdose, and Mortality Rates
Injection drug users have been among the groups most impacted by the AIDS epidemic. Of the more than 1 million adults and adolescents in the United States estimated to have ever been diagnosed with AIDS, 31% were infected either through injection drug use or a combination of injection drug use and male-to-male sexual contact, making drug injection the second most common HIV transmission route after male-tomale sexual contact. 4 
Overview of HIV Prevalence and HIV Incidence among Study Participants
At their initial and follow-up interviews, ARIBBA study participants in both locations received HIV counseling and testing. 21 At baseline, 20% of the participants in Puerto Rico were HIV positive compared to 25% in New York. Three follow-up interviews were conducted at approximately 6, 36, and 42 months after the initial interview. Overall, more than 80% of the sample participated in at least 1 of the 3 followup interviews. The HIV incidence analysis is based on participants who were HIV negative at baseline and who had 2 to 4 interviews. The sample size was 723 persons; 455 in New York and 268 in Puerto Rico. Participants in Puerto Rico who were HIV negative at baseline became infected with the virus at a rate that was almost 4 times higher than their New York counterparts. Graph 3 shows the incidence rates for both locations (per 100 years at risk) and the corresponding 95% confidence intervals. In New York, the rate was .88 per 100 years at risk, compared to 3.37 per 100 years at risk in Puerto Rico. The rate in Puerto Rico is among the highest recently reported among populations of drug users anywhere in the United States and territories.
If examined as the percentage of persons in the baseline sample who became infected, in Puerto Rico, 23 of the 268 (8.58%) drug users who were HIV negative at their initial interview contracted the virus by follow-up. By comparison, 9 (1.97%) of the 455 HIV-negative participants in New York became infected.
Predictive and Protective Factors
We also examined the baseline variables that were significantly associated with HIV incidence, including predictors of infection as well as protective factors. Among participants in both locations, more frequent drug injection was associated with becoming infected. Participants who became infected injected drugs an average of 204 times a month, compared to an average of 116 times among those who did not become infected. In New York, smoking crack was significantly related to becoming infected with HIV, and in fact, all of the persons who became infected in New York were crack smokers. (Some of them had also injected drugs.)
In Puerto Rico, younger age and injecting drugs in a drug-shooting gallery were significantly related to becoming infected with HIV. Being enrolled in a methadone program was protective in not becoming infected. None of the participants in Puerto Rico who became infected were enrolled in a methadone program at baseline.
Comparison of Mortality Rates of Study Participants
We examined the mortality rates of study participants by using data from the Center for Disease Control and Prevention National Death Index. 16 The mortality rate among participants in Puerto Rico was more than 3 times larger than among participants in New York. The preliminary mortality rate through December 2001 was 4.8 per 100 years at risk in Puerto Rico, compared to 1.3 per 100 years at risk in New York.
Comparison of Drug Overdose Death Rates in Puerto Rico, New York State, and the United States
To further assess the impact of drug use on mortality, we examined trends of drug overdose deaths in Puerto Rico and New York State from 1990 to 2000, and compared them to the national average (Graph 4). In 1990, the New York State rate was similar to the national average (1.9 and 1.8 per 100 000 population, respectively). The rate in Puerto Rico was about twice as high (3.3). From 1990 to 1993, the drug overdose death rate in New York State almost tripled, increasing from 1.9 to 5.2 per 100 000. Thereafter, the rate declined until the year 2000, when the rate in New York State was 3.5, about three quarters of the national rate (4.5). In Puerto Rico, the rate began to increase in 1992 and continued an upward trend until 2000, when the rate reached 11.1, more than twice the national rate of 4.5 and 3 times higher than in New York State.
Discussion and Lessons Learned
The drug users who were interviewed in Puerto Rico engaged in riskier drug-using and sexual behaviors than their counterparts in New York. In Puerto Rico, participants who were injection drug users injected more frequently, shared syringes and drug paraphernalia more often, and were more likely to have multiple sex partners and engage in unprotected sex. They also had fewer HIV-prevention resources and drug treatment programs available to them than study participants in New York, and the capacity of drug treatment programs in Puerto Rico declined by over a third between 1998 and 2002. The combination of high-risk behaviors and lack of access to services increased the likelihood that they would become infected with HIV.
Participants in Puerto Rico who were HIV negative at their baseline interview became infected at a rate that was almost 4 times higher than their New York counterparts, and they died at a rate that was more than 3 times higher. The HIV incidence rate in Puerto Rico is among the highest recently found among populations of drug users anywhere in the United States and its territories. While these findings are based on data collected several years ago, HIV/AIDS continues to exact a significant health and social toll on the population of Puerto Rico. A CDC/Puerto Rico Department of Health report based on 2006 data and published in 2009 found the HIV incidence rate to be twice that of the US, and that most transmissions were related to injection drug use. 5 While the findings of this study provide evidence of a public health emergency among drug users in Puerto Rico, it has broader social and public health implications. HIV and AIDS impose financial strains on an already overburdened health care system. Moreover, HIV's primary transmission route in the non-drug-using and heterosexual populations has historically been related to injection drug use, via sexual partners who are injection drug users. It is also likely a contributing factor to the rates of infection in the general population, including children.
There is no single method to prevent HIV transmission among drug users or other populations. However, the AIDS epidemic, now in its third decade, has led to the development and evaluation of many prevention interventions proven to be effective. Together, these interventions can have a significant impact in reducing HIV risk behaviors, thereby decreasing the number of persons who become infected.
The lessons learned and recommendations that follow are based on HIV prevention and risk reduction interventions that have been scientifically evaluated and shown to reduce the injection and sex risks of drug users. They are based on ARIBBA findings and the evaluation research literature of HIV prevention among drug users. These prevention methods form the core of an effective strategy to reduce new infections among drug users. In addition to these structural-level recommendations, there are also many individual-level interventions that have been found to be effective in reducing HIV risk behaviors. 22, 23 
Increase Access to Methadone Maintenance and Other Drug Treatment Programs
Methadone maintenance treatment has been critical in preventing HIV infections among injection drug users. It is particularly important in Puerto Rico, where the study found that enrollment in a methadone program was protective in not becoming infected. Methadone reduces the addict's physiological dependency on heroin and can reduce heroin consumption and injection frequency. Methadone maintenance may also lead to cessation of drug use. In addition, methadone maintenance programs can provide other services to support drug use reduction or abstinence, including case management and referral to health care, HIVrelated programs, and other drug-treatment modalities.
Access to methadone maintenance and to other drugtreatment programs should be expanded. This can be accomplished by adding resources to existing programs (to expand program capacity) and by developing new programs in underserved areas, as well as by expanding prison-based drug treatment.
Increase Street Outreach Programs
Because of the illicit nature of drug use, drug users, particularly those who inject drugs, are often suspicious of outsiders. They are considered ''hard-to reach'' and ''hidden'' populations. For this reason, HIV prevention and treatment programs frequently employ street outreach workers, some of whom are recovering drug users and are indigenous to the areas they work in, to reach and engage drug users and provide street-based services. Outreach workers typically provide verbal and written information on ways to reduce HIV risk and information and referrals to health care, social services, and drug-treatment programs. They also distribute risk reduction materials, such as condoms and bleach kits. Injecting drugs in a shooting gallery (a location where drugs are injected) was significantly related to becoming infected with HIV among the study's participants in Puerto Rico. Outreach workers can contribute to reducing the high-risk injection that occurs in shooting galleries by referring users there to drug treatment, risk reduction, and health programs. More generally, they can refer drug users who are not enrolled in drug treatment programs or using health services, and who are therefore at highest risk of contracting or transmitting HIV.
Increase Access to Clean Needles and Injection Equipment
Injection drug users who share syringes or injection equipment are at increased risk of HIV infection. If they are already infected, they can transmit the virus to others through sharing needles or other paraphernalia. In the month before their first interview, 20% of injection drug users in Puerto Rico used someone else's needle and a third used someone else's injection equipment.
Several studies have evaluated the effectiveness of NEPs and found that they reduce risky drug injection practices. Funding for syringe exchange programs should be increased and services expanded to regions that are underserved. Increasing access to new syringes reduces the likelihood that drug users will share them. Syringes can be distributed through several sources, including needle exchange programs, pharmacies, and health care workers.
Increase Access to HIV Medical Care
Medical treatments for persons who are HIV positive have advanced significantly since the start of the HIV/AIDS epidemic. Highly active antiretroviral therapy (HAART), which gained widespread use in 1996, has allowed persons who are HIV positive to live healthier and longer lives. Among study participants, nearly half of those in New York City and 78% of those in Puerto Rico reported that they were not taking HIV medications.
Treating drug users poses many challenges to medical providers, including that they may not take their medications on the schedules required, may continue to use drugs, and may miss appointments. Some studies have shown, however, that treatment adherence rates among drug users are similar to other groups. Despite the challenges, there are substantial benefits to individuals, as well as to the general population (through decreased transmission risk), to expanding access, engagement, and retention of HIV-positive drug users in HIV treatment. Expanding access can be accomplished through improving the linkages between drug treatment and HIV/AIDS service providers and through targeted outreach to drug users who are HIV positive and are not in treatment.
Develop an HIV Surveillance System
The HIV/AIDS surveillance system in Puerto Rico monitors the number of persons who are diagnosed with AIDS. An island-wide system for monitoring new infections, HIV incidence, is also needed, to compare infection rates across regions and populations, and to deploy public health and prevention resources to where they are most needed.
Tap the Influences of Prison Associations and Gangs to Reduce Risk
Drug users who reported injecting drugs while in prison reported high levels of sharing syringes and injection equipment. Three quarters of participants in Puerto Rico were members of gangs or prison associations during their incarcerations. While these groups are often associated with violence, both in and out of prison, findings from this and other studies suggest that gangs also influence the social norms of its members and what are considered acceptable and unacceptable behaviors.
Train Private Syringe Sellers to Work as HIV-Prevention Workers
Private syringe sellers may be able to serve a broader and more formal role in providing syringes to drug users, particularly during hours when NEPs and pharmacies are unavailable. These merchants are generally local vendors who do not use drugs and who work and live within drug-using areas. They were the largest single source of needles among injectors recruited in Puerto Rico. Syringe sellers can be trained as HIV-prevention workers, a role in which they would provide drug users with information on risk reduction and refer users to drug-treatment programs.
